A strategy to access unprecedented reactive intermediates featuring carbenes, carbocations, biradicals, and inverted σ-bonds via hypervalent λ3-haloganes
Proceedings of the Japan Academy, Series B · 2025
DOI: 10.2183/pjab.101.036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Proceedings of the Japan Academy, Series B, 2025. Verfasst von Kazunori Miyamoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, The University of Tokyo. Hauptthemen laut MEDLINE: Methane, Halogens. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science, Uehara Memorial Foundation, Asahi Glass Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, The University of Tokyo.
- Faculty of Pharmacy, Graduate School of Pharmaceutical Sciences, Keio University.
Förderung
- Japan Society for the Promotion of Science
- Uehara Memorial Foundation
- Asahi Glass Foundation
- Takeda Science Foundation
- Japan Science and Technology Agency
- Nagase Science Technology Foundation
- Sumitomo Foundation
Zitieren
APA
Miyamoto, K., & Uchiyama, M. (2025). A strategy to access unprecedented reactive intermediates featuring carbenes, carbocations, biradicals, and inverted σ-bonds via hypervalent λ3-haloganes. Proceedings of the Japan Academy, Series B. https://doi.org/10.2183/pjab.101.036
Vancouver
Miyamoto K, Uchiyama M. A strategy to access unprecedented reactive intermediates featuring carbenes, carbocations, biradicals, and inverted σ-bonds via hypervalent λ3-haloganes. Proceedings of the Japan Academy, Series B. 2025. doi:10.2183/pjab.101.036
BibTeX
@article{Miyamoto2025,
author = {Miyamoto, Kazunori and Uchiyama, Masanobu},
title = {A strategy to access unprecedented reactive intermediates featuring carbenes, carbocations, biradicals, and inverted σ-bonds via hypervalent λ3-haloganes},
journal = {Proceedings of the Japan Academy, Series B},
year = {2025},
doi = {10.2183/pjab.101.036}
}
EUVIMED